about
6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data.[PET and malignant cerebral tumors].Improvement of semi-quantitative small-animal PET data with recovery coefficients: a phantom and rat study.Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancerConsequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey.[18F]-FDG positron imaging in clinical management of lymphoma patients.A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: InflueDiagnosis of bone metastasis: recent comparative studies of imaging modalities.Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group.Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.(68)Ga-AMBA and (18)F-FDG for preclinical PET imaging of breast cancer: effect of tamoxifen treatment on tracer uptake by tumor.Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory disease.A Method to Improve the Semiquantification of 18F-FDG Uptake: Reliability of the Estimated Lean Body Mass Using the Conventional, Low-Dose CT from PET/CT.Evaluation of fluorodeoxyglucose positron emission tomography in the detection of axillary lymph node metastases in patients with early-stage breast cancer.Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer.[Diagnostic use of positron emission tomography in France: from the coincidence gamma-camera to mobile hybrid PET/CT devices].Nuclear medicine innovations help (drive) healthcare (benefits).[PET/CT in colorectal cancer].F-18 FDG PET/CT findings in pulmonary necrotizing sarcoid granulomatosis.Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma.Association of parathyroid adenoma and autonomous nodule of the thyroid. Diagnostic efficacy of 201thallium-99mtechnetium scintigraphy.[[18F]-fluorodeoxyglucose scintigraphy in digestive cancer][(18F)-fluoro-2-deoxyglucose PET in imaging of gynecologic cancers][Positron emission tomography (PET) with [18F]-FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation][Impact of [18F]-FDG-PET on medical decision making in oncology: evaluation by the referring physicians during the opening year].Fluorodeoxyglucose imaging using a coincidence gamma camera to detect head and neck squamous cell carcinoma and response to chemotherapy.Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results.Diffusely increased F-18 FDG uptake in bone marrow in a patient with acute anemia and recent erythropoietin therapy.Endometriosis with FDG uptake on PET.[Assessment of a neuroendocrine tumour by 111In-pentetreotid scintigraphy and PET with 18FFDOPA and 18F-FDG][Correlation in imaging techniques for the early detection of bone metastases in a case of breast cancer].[FDG PET/CT and childhood Hodgkin lymphoma].Fluorine-18 fluorodeoxyglucose with positron emission tomography revealed bone marrow involvement in sarcoidosis patients with anaemia.Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.Persistent foreign body reaction around inguinal mesh prostheses: a potential pitfall of FDG PET.Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?[Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].[Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
P50
Q30998485-05271D50-1CF3-4AF3-8D53-3E4C04730D57Q31060661-9BCAF9F4-D36A-47A8-B649-33DAB3845533Q31122939-1C657C63-0151-4DCB-A048-715DF0A9EA5CQ33946322-9DEDC04F-0854-4CED-A7AD-1204D3129101Q34040036-9705A573-E999-4C69-9EC3-65C2F11B7D8EQ34258569-BACD9CCA-3BC9-485F-A32E-9BFD6E311064Q36195528-0502B2E9-AA80-4639-A9DE-30181CD5AAEBQ37899009-52A9C07B-8E8F-478A-8886-5E87591F1B61Q38241465-956B01D1-EC85-4266-87C2-EDEC56C02928Q38360581-64372ACC-3DF6-4DCB-8B6A-23D43D5D0090Q38933767-309145FE-050D-438B-A1B4-85ECAE5FE25BQ39526862-241810BB-47E3-4657-8AB2-780BE1E8FCC0Q39909714-61C089DF-DE8A-4904-8091-1F4AEC04242BQ40156279-DB8940D9-48CE-4FF0-B599-78F2F6B5A56AQ42162774-BE252131-FBD6-48D1-9B03-42FC3D350FF8Q42178065-4FA8D73B-0760-4485-B8BE-A05C49D4DE75Q42725496-E40D2D75-9B92-4193-9FB3-C7EFBA7F9773Q42757682-D88AEEE3-C541-47C8-ADDC-5148E24D95C8Q42768725-A01ECC88-9BFF-4929-A520-A98454BF0D95Q42938927-D67857D2-F93B-4F1A-AF9A-EC424D40BAF5Q43437963-CCC53E36-680C-4719-B75D-66C4CABF66F4Q43489713-EC2677F0-F833-4DFB-8509-4F618EF0D2A7Q43671054-9AA93577-F702-4947-B0C4-4A6ACD98A8C4Q43841543-77C0D754-9F22-4C78-B60F-0B3952C54B09Q43940643-BFE43637-0D32-41D1-B352-1C322A72ECA8Q43952296-50142261-AE8C-4ADD-B8EF-E078D0276FDCQ44150226-1BF69D80-D02F-434D-BCDE-DE62001BE940Q44510110-4DB0C107-C24D-4C50-9BFA-EC6084443222Q44584327-02274E85-E157-48CD-A3BE-F1CF7294852AQ45149342-A0EFD97D-A743-4BF7-BEDE-DF4FA5E533FAQ45206161-F52BDADF-F516-49EA-A0EF-CFF58B0231C3Q45249463-89DE3BBD-D2E0-486E-BB30-AEF67A923736Q45961284-128B6B75-1DB0-4E5D-9B64-896F36751E40Q46107203-97940AD0-6864-4872-BF89-A3C0031D0B91Q46164645-D680BFF0-7B29-45D5-9256-3C43FEAEC1D6Q46402462-589A8537-0306-4C81-B210-32AFEF07C40FQ46631407-CE7A1785-74BB-4CCA-97ED-DCF4A7DD2C81Q46640662-5D1DC3D3-1263-4B84-BF7E-107C1580C39DQ46669714-D3F46B07-70B6-4425-9D41-7CD640223844Q46672835-8B9A1457-73BF-4762-9E65-B4B019CC8572
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
jean-noel talbot
@ast
jean-noel talbot
@en
jean-noel talbot
@nl
type
label
jean-noel talbot
@ast
jean-noel talbot
@en
jean-noel talbot
@nl
prefLabel
jean-noel talbot
@ast
jean-noel talbot
@en
jean-noel talbot
@nl
P106
P31
P496
0000-0002-3819-5013